Claudio Festuccia
Claudio Festuccia
Verified email at - Homepage
TitleCited byYear
Bombesin stimulates growth of human prostatic cancer cells in vitro
M Bologna, C Festuccia, P Muzi, L Biordi, M Ciomei
Cancer 63, 1714-1720, 1989
Triggering of human monocyte activation through CD69, a member of the natural killer cell gene complex family of signal transducing receptors.
R De Maria, MG Cifone, R Trotta, MR Rippo, A Santoni, T Roberto
Journal of Experimental Medicine 180, 1999-2004, 1994
Matrix-degrading proteinases are shed in membrane vesicles by ovarian cancer cells in vivo and in vitro
V Dolo, S D'Ascenzo, S Violini, L Pompucci, C Festuccia, A Ginestra, ...
Clinical & experimental metastasis 17 (2), 131-140, 1999
Plasminogen activator system modulates invasivecapacity and proliferation in prostatic tumor cells
C Festuccia, V Dolo, F Guerra, S Violini, P Muzi, A Pavan, M Bologna
Clinical & experimental metastasis 16 (6), 513-528, 1998
Nucleo-cytoplasmic transport as a therapeutic target of cancer
GL Gravina, W Senapedis, D McCauley, E Baloglu, S Shacham, ...
Journal of hematology & oncology 7 (1), 85, 2014
Biological rationale for the use of DNA methyltransferase inhibitors as new strategy for modulation of tumor response to chemotherapy and radiation
GL Gravina, C Festuccia, F Marampon, VM Popov, RG Pestell, BM Zani, ...
Molecular cancer 9 (1), 305, 2010
Osteoblast conditioned media contain TGF‐β1 and modulate the migration of prostate tumor cells and their interactions with extracellular matrix components
C Festuccia, M Bologna, GL Gravina, F Guerra, A Angelucci, I Villanova, ...
International journal of cancer 81 (3), 395-403, 1999
Suppression of EGF-R signaling reduces the incidence of prostate cancer metastasis in nude mice
A Angelucci, GL Gravina, N Rucci, D Millimaggi, C Festuccia, P Muzi, ...
Endocrine-related cancer 13 (1), 197-210, 2006
Vitamin D Protects Human Endothelial Cells from H2O2 Oxidant Injury Through the Mek/Erk-Sirt1 Axis Activation
L Polidoro, G Properzi, F Marampon, GL Gravina, C Festuccia, ...
Journal of cardiovascular translational research 6 (2), 221-231, 2013
Inhibition of interleukin-8 (CXCL8/IL-8) responses by repertaxin, a new inhibitor of the chemokine receptors CXCR1 and CXCR2
F Casilli, A Bianchini, I Gloaguen, L Biordi, E Alesse, C Festuccia, ...
Biochemical pharmacology 69 (3), 385-394, 2005
Pyrrolopyrimidine c-Src inhibitors reduce growth, adhesion, motility and invasion of prostate cancer cells in vitro
I Recchia, N Rucci, C Festuccia, M Bologna, AR Mackay, S Migliaccio, ...
European Journal of Cancer 39 (13), 1927-1935, 2003
Prostate cancer cell proliferation is strongly reduced by the epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 in vitro on human cell lines and primary cultures
C Vicentini, C Festuccia, GL Gravina, A Angelucci, A Marronaro, ...
Journal of cancer research and clinical oncology 129 (3), 165-174, 2003
Vesicle-associated urokinase plasminogen activator promotes invasion in prostate cancer cell lines
A Angelucci, S D'ascenzo, C Festuccia, GL Gravina, M Bologna, V Dolo, ...
Clinical & experimental metastasis 18 (2), 163, 2000
Osteoblast‐derived TGF‐β1 modulates matrix degrading protease expression and activity in prostate cancer cells
C Festuccia, A Angelucci, GL Gravina, I Villanova, A Teti, A Abini, ...
International journal of cancer 85 (3), 407-415, 2000
Finasteride dose-dependently reduces the proliferation rate of the LnCap human prostatic cancer cell line in vitro
M Bologna, P Muzi, L Biordi, C Festuccia, C Vicentini
Urology 45 (2), 282-290, 1995
Epidermal growth factor modulates prostate cancer cell invasiveness regulating urokinase-type plasminogen activator activity
C Festuccia, A Angelucci, GL Gravina, L Biordi, D Millimaggi, P Muzi, ...
Thrombosis and haemostasis 93 (05), 964-975, 2005
Osteopontin enhances the cell proliferation induced by the epidermal growth factor in human prostate cancer cells
A Angelucci, C Festuccia, GL Gravina, P Muzi, L Bonghi, C Vicentini, ...
The Prostate 59 (2), 157-166, 2004
Osteoblasts modulate secretion of urokinase-type plasminogen activator (uPA) and matrix metalloproteinase-9 (MMP-9) in human prostate cancer cells promoting migration and …
C Festuccia, D Giunciuglio, F Guerra, I Villanova, A Angelucci, P Manduca, ...
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 11 …, 1999
Pyrazolo [3, 4-d] pyrimidines c-Src inhibitors reduce epidermal growth factor-induced migration in prostate cancer cells
A Angelucci, S Schenone, GL Gravina, P Muzi, C Festuccia, C Vicentini, ...
European Journal of Cancer 42 (16), 2838-2845, 2006
MEK/ERK inhibitor U0126 increases the radiosensitivity of rhabdomyosarcoma cells in vitro and in vivo by downregulating growth and DNA repair signals
F Marampon, GL Gravina, A Di Rocco, P Bonfili, M Di Staso, C Fardella, ...
Molecular cancer therapeutics 10 (1), 159-168, 2011
The system can't perform the operation now. Try again later.
Articles 1–20